Literature DB >> 3873200

Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders.

J C Stuart, J G Linn.   

Abstract

The use of dilute (1/10%) sodium hyaluronate (Healon) eyedrops has given definite subjective patient improvement in a variety of ocular surface disorders, especially keratitis sicca. No adverse effects of the sodium hyaluronate drops have been encountered in patients who have used the drops for as long as two years. Masked trials and objective improvement of corneal staining patterns have also confirmed its efficacy.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3873200

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN： 0003-4886


  17 in total

1.  Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.

Authors:  Juan Ye; Huina Zhang; Han Wu; Changjun Wang; Xin Shi; Jiajun Xie; Jinjing He; Jun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-24       Impact factor: 3.117

2.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.

Authors:  Pasquale Aragona; Vincenzo Papa; Antonio Micali; Marcello Santocono; Giovanni Milazzo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  Use of commercially available sodium hyaluronate 0.18% eye drops for corneal epithelial healing in diabetic patients.

Authors:  KietPhang Ling; Mae-Lynn Catherine Bastion
Journal:  Int Ophthalmol       Date:  2018-12-07       Impact factor: 2.031

4.  Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.

Authors:  P I Condon; C G McEwen; M Wright; G Mackintosh; R J Prescott; C McDonald
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

5.  Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.

Authors:  K Kamiya; M Nakanishi; R Ishii; H Kobashi; A Igarashi; N Sato; K Shimizu
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

6.  Synergistic Properties of Arabinogalactan (AG) and Hyaluronic Acid (HA) Sodium Salt Mixtures.

Authors:  Antonia Di Mola; Francesco Ferdinando Summa; Patrizia Oliva; Francesco Lelj; Stefano Remiddi; Ludovica Silvani; Antonio Massa
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

7.  Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers.

Authors:  S A Gandolfi; A Massari; J G Orsoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

8.  Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.

Authors:  J A P Gomes; R Amankwah; A Powell-Richards; H S Dua
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 9.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

10.  Controlled release of high molecular weight hyaluronic Acid from molecularly imprinted hydrogel contact lenses.

Authors:  Maryam Ali; Mark E Byrne
Journal:  Pharm Res       Date:  2009-01-21       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.